Product correctly added to cart.

discount label
AT-56
View 3D

Biosynth logo

AT-56

CAS: 162640-98-4

Ref. 3D-MGA64098

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 19 Jul 2024

Product Information

Name:
AT-56
Description:

AT-56 is a novel and well-tolerated drug that is used for the treatment of cancer. AT-56 has been shown to inhibit the activity of mineralocorticoid receptor (MR), which is a member of steroid hormone receptors. The MR regulates salt and water balance in the body, so inhibition of this receptor can lead to severe hypertension. AT-56 also has an antiangiogenic effect by inhibiting vascular endothelial growth factor (VEGF) production in endothelial cells. This leads to decreased choroidal neovascularization, which causes blindness due to damage to retinal pigment epithelium cells. AT-56 also induces cell lysis, which may be associated with its ability to induce apoptosis in cancer cells.
AT-56 binds to the tumor cell membrane with a high affinity and increases permeability through ion channels, leading to cell lysis and death.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
397.52 g/mol
Formula:
C25H27N5
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-MGA64098 AT-56

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".